Longitude Capital Partners IV, LLC - Insider Non-Derivative Transactions at Lexeo Therapeutics, Inc. (LXEO) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Nov 7, 2023, Longitude Capital Partners IV, LLC's relationship to Lexeo Therapeutics, Inc. (LXEO) is TenPercentOwner, and currently has 2,567,100 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LXEO insiders.
Data Source: SEC.
Longitude Capital Partners IV, LLC - Insider Non-Derivative Transactions at LXEO
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Nov 8, 2023 | C -- (Common Stock) | 1793429 | 0 | 1793429 |
| Nov 8, 2023 | C -- (Common Stock) | 319126 | 0 | 2112555 |
| Nov 8, 2023 | P -- (Common Stock) | 454545 | 11 | 2567100 |